日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Combination effects of amino acid transporter LAT1 inhibitor nanvuranlat and cytotoxic anticancer drug gemcitabine on pancreatic and biliary tract cancer cells

氨基酸转运体LAT1抑制剂nanvuranlat与细胞毒抗癌药吉西他滨联合对胰腺及胆道癌细胞的作用

Kou Nishikubo, Ryuichi Ohgaki, Xingming Liu, Hiroki Okanishi, Minhui Xu, Hitoshi Endou, Yoshikatsu Kanai

Inhibition of cancer-type amino acid transporter LAT1 suppresses B16-F10 melanoma metastasis in mouse models

抑制癌型氨基酸转运蛋白LAT1可抑制小鼠模型中B16-F10黑色素瘤的转移

Zitong Shi # ,Kazuko Kaneda-Nakashima # ,Ryuichi Ohgaki ,Minhui Xu ,Hiroki Okanishi ,Hitoshi Endou ,Shushi Nagamori ,Yoshikatsu Kanai

Phosphoproteomics revealed cellular signals immediately responding to disruption of cancer amino acid homeostasis induced by inhibition of L-type amino acid transporter 1

磷酸化蛋白质组学揭示了细胞信号立即响应由 L 型氨基酸转运蛋白 1 抑制引起的癌症氨基酸稳态破坏

Hiroki Okanishi, Ryuichi Ohgaki, Minhui Xu, Hitoshi Endou, Yoshikatsu Kanai

Pharmacologic inhibition of LAT1 predominantly suppresses transport of large neutral amino acids and downregulates global translation in cancer cells

药理学抑制 LAT1 主要抑制大分子中性氨基酸的运输,并下调癌细胞的整体翻译

Kou Nishikubo, Ryuichi Ohgaki, Hiroki Okanishi, Suguru Okuda, Minhui Xu, Hitoshi Endou, Yoshikatsu Kanai

Expression of L-type amino acid transporter 1 is a poor prognostic factor for Non-Hodgkin's lymphoma

型氨基酸转运蛋白 1 的表达是非霍奇金淋巴瘤的不良预后因素

Narangerel Jigjidkhorloo, Kohsuke Kanekura, Jun Matsubayashi, Daigo Akahane, Koji Fujita, Keiki Oikawa, Atsushi Kurata, Masakatsu Takanashi, Hitoshi Endou, Toshitaka Nagao, Akihiko Gotoh, Oyundelger Norov, Masahiko Kuroda

Prognostic values of L-type amino acid transporter 1 and CD98hc expression in breast cancer

L型氨基酸转运蛋白1和CD98hc表达对乳腺癌的预后价值

Masaaki Ichinoe, Tetuo Mikami, Nobuyuki Yanagisawa, Tsutomu Yoshida, Kiyomi Hana, Hitoshi Endou, Isao Okayasu, Norihiko Sengoku, Hideaki Ogata, Makoto Saegusa, Kazutoshi Shibuya, Yoshiki Murakumo

Amino acid transporter LAT1 in tumor-associated vascular endothelium promotes angiogenesis by regulating cell proliferation and VEGF-A-dependent mTORC1 activation

肿瘤相关血管内皮中的氨基酸转运蛋白 LAT1 通过调节细胞增殖和 VEGF-A 依赖的 mTORC1 激活来促进血管生成

Lili Quan, Ryuichi Ohgaki, Saori Hara, Suguru Okuda, Ling Wei, Hiroki Okanishi, Shushi Nagamori, Hitoshi Endou, Yoshikatsu Kanai

Inhibition of the amino-acid transporter LAT1 demonstrates anti-neoplastic activity in medulloblastoma

抑制氨基酸转运蛋白 LAT1 可显示出对髓母细胞瘤的抗肿瘤活性

Yann Cormerais, Marina Pagnuzzi-Boncompagni, Sandra Schrötter, Sandy Giuliano, Eric Tambutté, Hitoshi Endou, Michael F Wempe, Gilles Pagès, Jacques Pouysségur, Vincent Picco

The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5)

谷氨酰胺转运蛋白 ASCT2(SLC1A5)独立于氨基酸转运蛋白 LAT1(SLC7A5)促进肿瘤生长

Yann Cormerais, Pierre André Massard, Milica Vucetic, Sandy Giuliano, Eric Tambutté, Jerome Durivault, Valérie Vial, Hitoshi Endou, Michael F Wempe, Scott K Parks, Jacques Pouyssegur

JPH203, a selective L-type amino acid transporter 1 inhibitor, induces mitochondria-dependent apoptosis in Saos2 human osteosarcoma cells

JPH203 是一种选择性 L 型氨基酸转运蛋白 1 抑制剂,可诱导 Saos2 人骨肉瘤细胞中线粒体依赖性细胞凋亡

Dae Woo Choi, Do Kyung Kim, Yoshikatsu Kanai, Michael F Wempe, Hitoshi Endou, Jong-Keun Kim